Literature DB >> 19132201

Ischaemic stroke patients with heterozygous factor V Leiden present with multiple brain infarctions and widespread atherothrombotic disease.

Elena Haapaniemi1, Johanna Helenius, Dimitrije Jakovljević, Lauri Soinne, Martti Syrjälä, Markku Kaste, Riitta Lassila, Turgut Tatlisumak.   

Abstract

Factor V Leiden (FVL) mutation is a risk factor for venous and, to a degree, arterial thrombosis. It is unknown whether and how FVL affects the manifestations of ischaemic stroke (IS). We assessed the clinical, laboratory, radiological, and prognostic characteristics in an observational study with adult IS patients having FVL. We tested 860 patients with first-ever IS for FVL and found 48 FVL positive patients. Detailed clinical, laboratory, and radiological evaluation were compared with that of 144 (1:3) gender and age matched IS patients without FVL. All patients underwent a prognostic evaluation at an average of five years follow-up. Despite the relatively young age (mean 48.5 years, range 44-54 years) of the FVL positive IS patients, peripheral arterial occlusive disease (PAOD), coronary artery disease (CAD), and previous transient cerebrovascular event occurred more frequently compared with controls. Family history of cardiovascular disease (CVD) and multiple silent brain infarctions were revealed in half of the FVL positive patients, whereas these were seldom encountered among controls. Stroke severity, long-term recovery, and recurrence rates seemed similar irrespective of FVL status. Our findings indicate that the clinical profile of IS patients with FVL associated with wider manifestation of atherothrombosis, positive family history of arterial thrombosis, and presence of multiple silent infarctions on brain images.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19132201

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  5 in total

1.  Ischemic stroke in a patient with hetrozygous factor v leiden mutation: an uncommon association.

Authors:  P S Ghalaut; Joginder Duhan; Vikas Chaudhary; Hemant Krishan Dahiya; Sumin Kaushik; Manisha Sharma; Jitendra Kumar Pehalajani
Journal:  Indian J Hematol Blood Transfus       Date:  2014-05-04       Impact factor: 0.900

2.  Posterior reversible encephalopathy syndrome, preeclampsia or stroke? A diagnostic dilemma.

Authors:  Vikesh Patel; Bhavna Ramachandran; Ifrah Omar
Journal:  BMJ Case Rep       Date:  2019-07-27

3.  Cerebral ischemia in young patients (under 45 years of age): clinical and neuroradiological follow-up.

Authors:  Rosalba Patella; Alessandra Spalloni; Marco Ferrari; Sara La Starza; Alessandro Bozzao; Maurizia Rasura
Journal:  Neurol Sci       Date:  2011-03-02       Impact factor: 3.307

4.  Is there a relationship between factor V Leiden and type 2 diabetes?

Authors:  Corrado Lodigiani; Paola Ferrazzi; Pierpaolo Di Micco; Luca Librè; Stefano Genovese; Ilaria Quaglia; Lidia Luciana Rota
Journal:  J Transl Med       Date:  2009-06-26       Impact factor: 5.531

5.  Study of Prothrombotic Gene Variations Associated with the Risk of Development of Thrombosis in Patients with Down Syndrome.

Authors:  Chandreswara Raju Kataru; Vinodhini Krishnakumar; Inusha Panigrahi; Meganathan Kannan
Journal:  Indian J Hematol Blood Transfus       Date:  2020-10-17       Impact factor: 0.915

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.